Harel Insurance Investments & Financial Services Ltd. boosted its position in Northrop Grumman Corporation by 4.1% during the third quarter, purchasing an additional 3,215 shares to bring its total to 81,747 shares. At the end of the period, Harel’s stake was valued at approximately $49.81 million, representing 0.06% of Northrop Grumman’s outstanding shares. This increase underscores continued confidence from a major institutional holder in the company’s long-term growth prospects.

In the third quarter, Northrop Grumman reported adjusted earnings per share of $7.67, beating consensus estimates by $1.24. Revenue for the quarter reached $10.42 billion, reflecting a 4.3% year-over-year increase. The company achieved a return on equity of 25.5% and a net margin of 9.8%, driven by robust performance in its aerospace systems and missile defense segments. Management reaffirmed full-year guidance of $25.65 to $26.05 in EPS, with analysts now projecting $28.05 for the current fiscal year.

A total of nineteen analysts have weighed in with a consensus rating of Moderate Buy on Northrop Grumman. Two firms have issued Strong Buy recommendations, twelve have Buy ratings and seven maintain a Hold stance. Recent upgrades include Alembic Global Advisors’ move to Overweight and Susquehanna’s reiteration of a Positive outlook. Average price targets provided by these analysts cluster around $657, reflecting expectations for continued margin expansion and contract awards in defense programs.

Northrop Grumman declared a quarterly dividend of $2.31, payable to shareholders of record on December 1, representing a $9.24 annualized payout and a dividend yield of approximately 1.4%. Insider transactions during the past quarter included the sale of 7,097 shares by senior executives, reducing aggregate insider holdings by 2.4%. These sales were disclosed in filings with the Securities and Exchange Commission and are consistent with pre-arranged trading plans rather than changes in insider sentiment about the company’s outlook.